Increased high-frequency NREM EEG power associated with mindfulness-based interventions for chronic insomnia: Preliminary findings from spectral analysis.


Journal

Journal of psychosomatic research
ISSN: 1879-1360
Titre abrégé: J Psychosom Res
Pays: England
ID NLM: 0376333

Informations de publication

Date de publication:
05 2019
Historique:
received: 06 10 2018
revised: 26 02 2019
accepted: 26 02 2019
entrez: 2 4 2019
pubmed: 2 4 2019
medline: 30 4 2020
Statut: ppublish

Résumé

Mindfulness-based interventions (MBI) have been shown to reduce subjective symptoms of insomnia but the effects on objective measures remain unclear. The purpose of this study was to examine sleep EEG microarchitecture patterns from a randomized controlled trial of Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Therapy for Insomnia (MBTI). Sleep EEG spectral analysis was conducted on 36 participants with chronic insomnia (>6 months) randomized to 8-week MBSR, MBTI, or self-monitoring control (SM). Overnight polysomnography with 6-channel EEG was conducted at baseline, post-treatment, and 6-month follow-up. Spectral power averaged from channels C3/C4 across NREM epochs (excluding N1) was examined for within-group changes and relationships with self-report measures. Increases in absolute NREM beta (16-25 Hz) power were observed from baseline to post-treatment (p = .02, d = 0.53) and maintained at 6-month follow-up (p = .01, d = 0.57) in the combined MBI groups, and additionally in the gamma (25-40 Hz) range at follow-up for the MBTI group only. No significant changes in these frequency bands were observed for SM. Following mindfulness intervention, NREM beta was positively associated with Five-Facet Mindfulness (FFM) score (rho = 0.37, p = .091) and negatively associated with Insomnia Severity Index (rho = -0.43, p = .047). These results in people with insomnia corroborate prior reports of increased high-frequency sleep EEG power associated with mindfulness training. This change in beta EEG pattern merits further evaluation as a potential marker of the effects of mindfulness meditation on sleep, especially given the paradoxical findings in the context of insomnia. clinicaltrials.gov, NCT00768781.

Identifiants

pubmed: 30929703
pii: S0022-3999(18)30891-2
doi: 10.1016/j.jpsychores.2019.02.012
pmc: PMC8497013
mid: NIHMS1743632
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT00768781']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-19

Subventions

Organisme : NCCIH NIH HHS
ID : K23 AT003678
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH066992
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007909
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

J Sleep Res. 2005 Dec;14(4):401-7
pubmed: 16364141
J Sleep Res. 2001 Jun;10(2):93-104
pubmed: 11422723
Behav Res Ther. 2017 Oct;97:230-241
pubmed: 28858698
Sleep. 2016 Apr 01;39(4):801-12
pubmed: 26943465
J Psychosom Res. 2016 Oct;89:1-6
pubmed: 27663102
Biol Psychol. 2012 Dec;91(3):329-33
pubmed: 22960269
Ann Intern Med. 2016 Jul 19;165(2):125-33
pubmed: 27136449
Psychosom Med. 2003 Jul-Aug;65(4):564-70
pubmed: 12883106
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Sleep. 2008 Dec;31(12):1673-82
pubmed: 19090323
Sleep Med Rev. 2010 Feb;14(1):19-31
pubmed: 19481481
Psychoneuroendocrinology. 2013 Dec;38(12):3160-6
pubmed: 24054762
J Sleep Res. 2004 Dec;13(4):385-93
pubmed: 15560773
Sleep. 2010 May;33(5):669-77
pubmed: 20469809
Sleep. 2001 Feb 1;24(1):110-7
pubmed: 11204046
J Psychosom Res. 2001 Aug;51(2):435-41
pubmed: 11516766
Cancer Manag Res. 2015 Jun 01;7:121-31
pubmed: 26064068
Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16369-73
pubmed: 15534199
Psychol Bull. 2006 Mar;132(2):180-211
pubmed: 16536641
Behav Res Ther. 1985;23(3):263-71
pubmed: 4004706
Psychosom Med. 2010 Jul;72(6):539-48
pubmed: 20467003
Hum Psychopharmacol. 2016 Jan;31(1):70-4
pubmed: 26494125
JAMA. 2013 Feb 20;309(7):706-16
pubmed: 23423416
Assessment. 2006 Mar;13(1):27-45
pubmed: 16443717
PLoS One. 2013 Aug 28;8(8):e73417
pubmed: 24015304
Sleep Med Rev. 2001 Oct;5(5):363-374
pubmed: 12531000
Explore (NY). 2007 Nov-Dec;3(6):585-91
pubmed: 18005910
Curr Sleep Med Rep. 2017 Jun;3(2):57-65
pubmed: 30294523
Ann N Y Acad Sci. 2016 Jun;1373(1):13-24
pubmed: 26799456
Sleep Med Rev. 2010 Feb;14(1):9-15
pubmed: 19640748
Ann N Y Acad Sci. 2014 Jan;1307:64-81
pubmed: 24372471
Sleep. 2014 Sep 01;37(9):1553-63
pubmed: 25142566
Sleep. 2012 Sep 01;35(9):1285-91
pubmed: 22942507

Auteurs

Michael R Goldstein (MR)

Department of Psychology, University of Arizona, Tucson, AZ, United States of America.

Arlener D Turner (AD)

Department of Human Services and Psychology, National Louis University, Chicago, IL, United States of America.

Spencer C Dawson (SC)

Department of Neurology, Center for Circadian and Sleep Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.

Zindel V Segal (ZV)

Department of Psychological Clinical Science, University of Toronto - Scarborough, Toronto, ON, Canada.

Shauna L Shapiro (SL)

Department of Counseling Psychology, Santa Clara University, Santa Clara, CA, United States of America.

James K Wyatt (JK)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, United States of America.

Rachel Manber (R)

Department of Psychiatry and Behavioral Sciences, Stanford University Medical School, Palo Alto, CA, United States of America.

David Sholtes (D)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, United States of America.

Jason C Ong (JC)

Department of Neurology, Center for Circadian and Sleep Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America. Electronic address: jason.ong@northwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH